Paul Szabolcs
Clinical trials sponsored by Paul Szabolcs, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Milder transplant method aims to help young patients with rare blood diseases Results expected Nov 2026 (estimated)
- Double transplant breakthrough offers hope for rare immune disorder patients Results expected Nov 2026 (estimated)
- Can stem cells tame severe Crohn's? new trial aims to find out Results expected Dec 2026 (estimated)
-
Lab-Grown immune cells take aim at Life-Threatening viruses in vulnerable patients
Disease control By invitation onlyThis study tests whether specially grown immune cells can fight three common viruses—adenovirus, CMV, and EBV—in people whose immune systems are weak due to a stem cell or organ transplant, or an inherited immune disorder. The cells are made from a donor's blood and trained to re…
Phase 1/2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Double transplant breakthrough offers hope for rare immune disorder patients
Disease control By invitation onlyThis study tests a new approach for people aged 5 to 45 with primary immune deficiencies and end-stage lung disease. Participants receive a double lung transplant followed by a stem cell transplant from the same donor. The goal is to see if this combined procedure is safe and can…
Phase 1/2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC